Uncovering causal clues in the development of second primary cancers - Authors' reply

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Standard

Uncovering causal clues in the development of second primary cancers - Authors' reply. / Kjaer, Trille Kristina; Johansen, Christoffer; Dalton, Susanne Oksbjerg.

I: The Lancet. Oncology, Bind 25, Nr. 3, 2024, s. e98.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Harvard

Kjaer, TK, Johansen, C & Dalton, SO 2024, 'Uncovering causal clues in the development of second primary cancers - Authors' reply', The Lancet. Oncology, bind 25, nr. 3, s. e98. https://doi.org/10.1016/S1470-2045(24)00090-1

APA

Kjaer, T. K., Johansen, C., & Dalton, S. O. (2024). Uncovering causal clues in the development of second primary cancers - Authors' reply. The Lancet. Oncology, 25(3), e98. https://doi.org/10.1016/S1470-2045(24)00090-1

Vancouver

Kjaer TK, Johansen C, Dalton SO. Uncovering causal clues in the development of second primary cancers - Authors' reply. The Lancet. Oncology. 2024;25(3):e98. https://doi.org/10.1016/S1470-2045(24)00090-1

Author

Kjaer, Trille Kristina ; Johansen, Christoffer ; Dalton, Susanne Oksbjerg. / Uncovering causal clues in the development of second primary cancers - Authors' reply. I: The Lancet. Oncology. 2024 ; Bind 25, Nr. 3. s. e98.

Bibtex

@article{4aba658c98f142a89b213f90c125df89,
title = "Uncovering causal clues in the development of second primary cancers - Authors' reply",
author = "Kjaer, {Trille Kristina} and Christoffer Johansen and Dalton, {Susanne Oksbjerg}",
year = "2024",
doi = "10.1016/S1470-2045(24)00090-1",
language = "English",
volume = "25",
pages = "e98",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "TheLancet Publishing Group",
number = "3",

}

RIS

TY - JOUR

T1 - Uncovering causal clues in the development of second primary cancers - Authors' reply

AU - Kjaer, Trille Kristina

AU - Johansen, Christoffer

AU - Dalton, Susanne Oksbjerg

PY - 2024

Y1 - 2024

U2 - 10.1016/S1470-2045(24)00090-1

DO - 10.1016/S1470-2045(24)00090-1

M3 - Comment/debate

C2 - 38423066

AN - SCOPUS:85186370830

VL - 25

SP - e98

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 3

ER -

ID: 385129940